Zurex Pharma, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2010-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.zurex-pharma.com
Clinical Trials
9
Active:0
Completed:8
Trial Phases
3 Phases
Phase 1:2
Phase 2:2
Phase 3:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Phase 3
5 (55.6%)Phase 1
2 (22.2%)Phase 2
2 (22.2%)Perioperative Patient Skin Antiseptic Preparation Evaluation
Phase 3
Completed
- Conditions
- Surgical Site Infection
- Interventions
- Drug: 70% v/v Isopropyl Alcohol Surgical Solution
- First Posted Date
- 2021-02-16
- Last Posted Date
- 2024-03-20
- Lead Sponsor
- Zurex Pharma, Inc.
- Target Recruit Count
- 51
- Registration Number
- NCT04756804
- Locations
- 🇺🇸
MCW/FH, Milwaukee, Wisconsin, United States
In-vivo Efficacy of Patient Preoperative Prep, ZuraPrep (ZP)
Phase 3
Completed
- Conditions
- Surgical Skin Preparation
- Interventions
- Drug: ZuraPrep VehicleDrug: ChloraPrepDrug: ZuraPrep Clear Solution
- First Posted Date
- 2018-12-20
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Zurex Pharma, Inc.
- Target Recruit Count
- 156
- Registration Number
- NCT03782103
- Locations
- 🇺🇸
Microbac Laboratories, Inc., Sterling, Virginia, United States
In-vivo Efficacy of Patient Preoperative Prep
Phase 3
Completed
- Conditions
- Surgical Skin Preparation
- Interventions
- Drug: ZP VehicleDrug: ZuraPrepDrug: ChloraPrep
- First Posted Date
- 2016-07-13
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Zurex Pharma, Inc.
- Target Recruit Count
- 440
- Registration Number
- NCT02831998
- Locations
- 🇺🇸
MicroBioTest Laboratories, Sterling, Virginia, United States
Clinical Evaluation of Patient Preoperative Prep
Phase 3
Completed
- Conditions
- Surgical Skin Preparation
- Interventions
- Drug: ZuraPrepDrug: ZP VehicleDrug: ChloraPrep
- First Posted Date
- 2016-07-13
- Last Posted Date
- 2021-07-16
- Lead Sponsor
- Zurex Pharma, Inc.
- Target Recruit Count
- 640
- Registration Number
- NCT02831816
- Locations
- 🇺🇸
BioScience Laboratories, Inc., Bozeman, Montana, United States
Pilot Clinical Evaluation to Characterize in Vivo Effects of Topically Applied ZuraPrep & ZuraPrep Vehicle
Phase 3
Completed
- Conditions
- Surgical Site Infection
- Interventions
- Drug: ZuraPrep with 70% IPADrug: ZuraPrep without 70% IPADrug: ChloraPrep CHG/IPA Teal TintOther: Normal Saline
- First Posted Date
- 2015-10-19
- Last Posted Date
- 2017-07-17
- Lead Sponsor
- Zurex Pharma, Inc.
- Target Recruit Count
- 123
- Registration Number
- NCT02578771
- Locations
- 🇺🇸
MicroBioTest, Sterling, Virginia, United States
- Prev
- 1
- 2
- Next
News
No news found